Structura Biotechnology
Engineering Software · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 Crescent Town Rd Apt 412, Toronto, Ont...Website
structura.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
2
1
1
1
About Structura Biotechnology
Structura Biotechnology specializes in cryo-electron microscopy (cryo-EM) technology, providing high-throughput structure determination techniques essential for life sciences and drug discovery. Their flagship product, the CryoSPARC platform, offers advanced software solutions and proprietary algorithms designed for the analysis and 3D reconstruction of proteins, including membrane proteins and drug targets. Founded in 2016, the company has rapidly developed its software capabilities, releasing multiple versions of CryoSPARC that enhance cryo-EM data processing and modeling. They aim to serve researchers and institutions in the biotechnology sector, especially those involved in molecular biology and vaccine development.Explore more
Structura Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Structura Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Structura Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Structura Biotechnology launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Structura Biotechnology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Structura Biotechnology
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Structura Biotechnology is spiking on competitors!
Click to see if Structura Biotechnology had a recent Job posting/layoffs
Earning: See what the market has to say on Structura Biotechnology recently announced quarterly report
Structura Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Structura Biotechnology
Compare insights from companies similar to Structura Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Structura Biotechnology is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Structura Biotechnology is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Structura Biotechnology.
Structura Biotechnology Tech Stack
A closer look at the technologies used by Structura Biotechnology
Structura Biotechnology News & Media
3D visualization software startup PreVu3D raises $2.5 million seed round
PreVu3D, a Montreal-based startup that has developed an interactive 3D visualization and modelling software solution, has raised a $2.5 million CAD seed round.
Read more news
Top Engineering Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Structura Biotechnology
Sign Up For FreeTo access detailed company insights
Structura Biotechnology specializes in cryo-electron microscopy (cryo-EM) technology, providing high-throughput structure determination techniques essential for life sciences and drug discovery. Their flagship product, the CryoSPARC platform, offers advanced software solutions and proprietary algorithms designed for the analysis and 3D reconstructi... Read More
